For cancer survivors, taking oral medication may be more convenient than spending hours undergoing infusions, but it could come with trade-offs, according to a Michigan State University researcher and her colleagues.
Alla Sikorskii, a professor in the MSU College of Osteopathic Medicine’s Department of Psychiatry. By taking these oral medications, survivors may see their oncology teams less often, requiring them to deal with symptoms like fatigue, depression or skin rashes on their own. Unmanaged symptoms can result in cancer treatment interruptions or even lead to emergency room visits, said Alla Sikorskii, a professor in the MSU College of Osteopathic Medicine’s Department of Psychiatry.
Olorunseun “Seun” Ogunwobi to lead biochemistry and molecular biology department, establish Center for Cancer Health Equity Research
Internationally renowned cancer researcher Olorunseun “Seun” Ogunwobi will join Michigan State University on Aug. 16 as chair of the Department of Biochemistry and Molecular Biology, which is affiliated with the College of Natural Science, the College of Human Medicine and the College of Osteopathic Medicine.
Michigan State University is a top global research university and a member of the prestigious Association of American Universities, widely regarded as among the top research-intensive institutions in North America. The following story highlights one of the many examples of MSU’s research excellence and innovation.
Meghan Hill is a graduate student in the Department of Biomedical Engineering at Michigan State University. Hill has won first place in MSU’s Council of Graduate Student’s 3-Minute Thesis Competition and represented MSU at the regional Midwestern Association of Graduate School’s thesis competition in Chicago. Most recently, she was awarded a dissertation completion fellowship through MSU’s College of Engineering. Hill’s research with Prussian blue nanoparticles will improve cancer research.